STE vs VXRT · P/E 25, rev $5.46B vs rev $28.7M
STERIS plc (STE) versus Vaxart Inc (VXRT) — a side-by-side from cached financials, not a winner call.
STERIS plc (STE) is a medical devices company listed on NYSE.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
STE currently screens at market cap $19.43B and trailing P/E 25.1. VXRT currently screens at market cap $73.0M.
Not investment advice. Open the STE and VXRT stock pages for the full models.
Not investment advice.